Skip to content

A study to evaluate the correlation of the cobas 4800 CT/NG test with the Abbott m2000 CT/NG test

A study to evaluate the correlation of the cobas 4800 CT/NG test with the Abbott m2000 CT/NG test - cobas CT/NG test

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33357
Enrollment
1200
Registered
2009-07-08
Start date
2009-11-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chlamydia STD

Interventions

None listed

Sponsors

Roche Molecular Systems (RMS)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Suspected for STD

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The statistical analyses will be performed separately for each type of specimen. The positive correlation, negative correlation and overall agreement (total concordance) of the cobas 4800 CT/NG Test to the Abbott m2000 CT/NG Test will be calculated along with the 95% confidence intervals. Calculations will be done with initial results as well as final resolved results. The cobas 4800 CT/NG Test and the Abbott m2000 CT/NG Test shall be considered equivalent by having the exact 95% (one-sided) confidence bound for percent Chlamydia trachomatis positive specimen greater than 90%. The cobas 4800 CT/NG Test and the Abbott m2000 CT/NG Test shall be considered equivalent by having the exact 95% (one-sided) confidence bound for percent Neisseria gonorrhoeae positive specimen greater than 90%. In the event that the final samples sizes for the endocervical swab CT and/or NG positive specimens falls below 50, an overall cobas 4800 CT/NG Test positive correlation of at least 95% must be met for both CT and NG to show equivalence to the Abbott m2000 CT/NG Test.

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)